sur Moderna, Inc. (NASDAQ:MRNA)
Moderna to Announce Q3 2025 Financial Results on November 6
Moderna, Inc. (NASDAQ: MRNA) has announced it will release its financial results for the third quarter of 2025 on Thursday, November 6. The announcement will occur during a live conference call and webcast set for 8:00 a.m. ET. Details of the presentation can be accessed on Moderna's website under "Events and Presentations" in the Investors section.
The webcast will be archived and accessible two hours after the live call. Interested parties will have the opportunity to review the presentation for a full year following the broadcast.
Moderna has made significant advancements in mRNA medicine, influencing the future of therapeutic and vaccine development. The company is known for pioneering one of the early COVID-19 vaccines, leveraging its mRNA technology platform for various health applications.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Moderna, Inc.